HB 21-Relating to Controlled Substances
On Wednesday, January 10th, HB 21 by Representative Jim Boyd (R-Bradenton) was heard before the House Health Quality Subcommittee and passed. AIF’s Senior Vice President of State and Federal Affairs, Brewster Bevis, stood in support of this bill.
This bill addresses opioid abuse by expanding the use of the Prescription Drug Monitoring Program (PDMP), increasing regulation of prescribers and dispensers, and aligning state criminal statutes with federal law. HB 21 limits the prescription for a Schedule II opioid to alleviate acute pain to a three-day supply, or a seven-day supply if deemed medically necessary by the prescriber.
The bill also requires the Department of Health (DOH) to adopt rules establishing guidelines for prescribing controlled substances for acute pain, similar to those for chronic pain. Additionally, The bill also requires a health care practitioner authorized to prescribe controlled substances to complete a board approved 2-hour continuing education course on safely and effectively prescribing controlled substances, and to review a patient’s PDMP history prior to prescribing or dispensing a controlled substance.
HB 21 will go on to the House Appropriations Committee to be heard.
AIF supports legislative efforts that aim to curb opioid abuse and addiction that is currently running rampant through the state effecting Florida’s families and businesses.